Altria Gains Regulatory Edge in Fast-Track Nicotine Pouch Review

Tobacco giant Altria may secure a significant competitive advantage in the rapidly expanding nicotine pouch market. In an unusual regulatory move, the U.S. Food and Drug Administration has included Altria’s “on! PLUS” nicotine pouches in an accelerated pilot program with a completion deadline set for December 2025. This streamlined process could grant the company regulatory approval within months rather than the years typically required through standard authorization channels.

Breaking from conventional procedures, the FDA’s pilot program will fast-track the evaluation of Altria’s products alongside competing offerings from Philip Morris, Reynolds American, and Turning Point Brands. This initiative represents a dramatic departure from previous timelines?Philip Morris’s popular Zyn pouches, for comparison, underwent a five-year review before receiving FDA Read more...